Evaluation of the Osteoinductivity of Atorvastatin Combined With β-TCP
Conditions: Infection; Bone Loss Interventions: Procedure: Cyst enucleation and bone grafting Sponsors: Cairo University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 25, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients
Conditions: Dyslipidemias; Statin Adverse Reaction; Cardiovascular Diseases; Lipid Metabolism Disorders Interventions: Drug: Lipid-lowering therapy combination with PCSK9 inhibitors, bempedoic acid and ezetimibe; Drug: Lipid-lowering therapy combination with PCSK9 inhibitors and ezetimibe Sponsors: University of Salerno Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 24, 2024 Category: Research Source Type: clinical trials
Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
Conditions: Pharmacokinetics Interventions: Drug: leramistat 40mg; Drug: Itraconazole 200 mg; Drug: Phenytoin 100 Mg Oral Capsule; Drug: Simvastatin 40mg Sponsors: Modern Biosciences Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 23, 2024 Category: Research Source Type: clinical trials
Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction
Conditions: Plaque, Atherosclerotic Interventions: Drug: atorvastatin; Procedure: IVUS/OCT; Drug: inclisiran Sponsors: Novartis Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Statins Role in Acute Ischemic Stroke
Conditions: Stroke, Acute Interventions: Drug: rosuvastatin Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
Conditions: Epilepsy; Dyslipidemia Interventions: Drug: Atorvastatin 10mg; Other: Modification of dietary fat composition Sponsors: Johns Hopkins University; American Heart Association Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Statins and Post-ERCP Acute Pancreatitis (Stark Project)
Conditions: Post-ERCP Acute Pancreatitis Interventions: Drug: Statin Sponsors: Hospital General Universitario de Alicante; European Pancreatic Club (EPC), Pancreas 2000 Educational Program Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Effects of PCSK-9 Inhibitor Treatment Prior to Undergoing Primary Percutaneous Coronary Intervention in Patients With ST-segment Elevation Myocardial Infarction
Conditions: STEMI Interventions: Drug: evolocumab; Drug: Atorvastatin Sponsors: Beijing Luhe Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 15, 2024 Category: Research Source Type: clinical trials
Combining Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Large-vessel Ischemic Stroke
Conditions: Ischemic Stroke Interventions: Drug: Atorvastatin 40 Mg Oral Tablet; Drug: Rosuvastatin 20mg Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Detoxification From the Lipid Tract
Conditions: COVID-19 Vaccine Adverse Reaction Interventions: Device: electroencephalogram biofeedback; Device: electrical brain stimulation; Device: ultra-low frequency transcranial magnetic stimulation; Drug: Sertraline Hydrochloride; Drug: Clonazepam; Drug: Alprazolam; Drug: Metoprolol; Drug: Olanzapine; Drug: Pravastatin Sodium 20 MG; Drug: Sacubitril Valsartan Sodium Hydrate Sponsors: Pachankis, Yang I., M.D.; First Affiliated Hospital of Chongqing Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Concomitant Use of Clopidogrel With Atorvastatin or Rosuvastatin in Patients With Minor Stroke or TIA
Conditions: Ischemic Stroke Interventions: Drug: Atorvastatin 40mg; Drug: Rosuvastatin 20mg Sponsors: Kafrelsheikh University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials
Effect of Statin Therapy on Sepsis-related Mortality in Intensive Care Unit Patients
Conditions: Sepsis; Septic Shock Interventions: Other: Person-level linkage of the database looking for relationship with sepsis survival and previous intake of certain drug families and previous dependence on health services. Sponsors: Hospital de Granollers; Department of Health, Generalitat de Catalunya Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 9, 2024 Category: Research Source Type: clinical trials
Clinical effects of atorvastatin combined with conbercept in the treatment of patients with macular edema secondary to retinal vein occlusion and carotid plaque: study protocol for a prospective randomized controlled trial
This study aims to observe the clinical effects of atorvastatin and intravitreal therapy in the treatment of patients with branch or central RVO-ME and coexistent carotid plaques (CP).Methods and analysisA prospective randomized controlled clinical trial will be conducted. Sixty-four patients diagnosed with branch or central RVO-ME and coexistent CP will be enrolled and randomly allocated in a 1:1 ratio to the control and experimental groups. The control group will be treated with intravitreal conbercept monthly for 3 months, followed by monthly evaluation and injection of pro re nata (PRN) for 12 months, while the experim...
Source: Trials - April 8, 2024 Category: Research Source Type: clinical trials
Osteogenic Action of a Biphasic Bioceramic With Statin in a Third Molar Extraction Model
Conditions: Bone Loss; Regenerative Inflammation Interventions: Combination Product: Biphasic bioceramic of tricalcium phosphate and hydroxyapatite with simvastatin; Other: Bovine Hydroxyapatite Sponsors: Mario P érez Sayáns; Universidad de Murcia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Effects of Inclisiran Combined With Statins on the Morphology of Coronary Vulnerable Plaques
Conditions: Coronary Artery Disease Interventions: Drug: Inclisiran sodium; Drug: Rosuvastatin Sponsors: Nanjing First Hospital, Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
